• Something wrong with this record ?

Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma

D. Shetti, VR. Mallela, W. Ye, M. Sharif, F. Ambrozkiewicz, A. Trailin, V. Liška, K. Hemminki

. 2024 ; 200 (-) : 104391. [pub] 20240523

Language English Country Netherlands

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc24019569

Hepatocellular carcinoma (HCC) is a severe neoplastic disease associated with high morbidity and mortality rates. HCC is often detected at advanced stages leading to ineffective curative treatments. Recently, liquid biopsy has emerged as a non-invasive method to identify highly specific HCC biomarkers in bodily fluids such as blood, serum, urine, and saliva. Circulating cell-free nucleic acids (cfNAs), particularly cell-free DNA (cfDNA) and cell-free RNA (cfRNA), have become promising candidates for biomarkers in liquid biopsy applications. While cfDNA presented significant challenges, researchers have turned their attention to cfRNA, which can be efficiently identified through various methods and is considered a potential biomarker for cancer diagnosis and prognosis. This review primarily focuses on studies related to detecting various cfRNA in body fluids as biomarkers. The aim is to provide a summary of available information to assist researchers in their investigations and the development of new diagnostic and prognostic tools.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019569
003      
CZ-PrNML
005      
20241024110627.0
007      
ta
008      
241015e20240523ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.critrevonc.2024.104391 $2 doi
035    __
$a (PubMed)38795877
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Shetti, Dattatrya $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic. Electronic address: dattakapilshetti@gmail.com
245    10
$a Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma / $c D. Shetti, VR. Mallela, W. Ye, M. Sharif, F. Ambrozkiewicz, A. Trailin, V. Liška, K. Hemminki
520    9_
$a Hepatocellular carcinoma (HCC) is a severe neoplastic disease associated with high morbidity and mortality rates. HCC is often detected at advanced stages leading to ineffective curative treatments. Recently, liquid biopsy has emerged as a non-invasive method to identify highly specific HCC biomarkers in bodily fluids such as blood, serum, urine, and saliva. Circulating cell-free nucleic acids (cfNAs), particularly cell-free DNA (cfDNA) and cell-free RNA (cfRNA), have become promising candidates for biomarkers in liquid biopsy applications. While cfDNA presented significant challenges, researchers have turned their attention to cfRNA, which can be efficiently identified through various methods and is considered a potential biomarker for cancer diagnosis and prognosis. This review primarily focuses on studies related to detecting various cfRNA in body fluids as biomarkers. The aim is to provide a summary of available information to assist researchers in their investigations and the development of new diagnostic and prognostic tools.
650    _2
$a lidé $7 D006801
650    12
$a hepatocelulární karcinom $x diagnóza $x krev $x genetika $7 D006528
650    12
$a nádory jater $x diagnóza $x genetika $x krev $7 D008113
650    12
$a nádorové biomarkery $x krev $x genetika $x analýza $7 D014408
650    12
$a volné cirkulující nukleové kyseliny $x krev $x analýza $7 D000073888
650    _2
$a tekutá biopsie $x metody $7 D000073890
650    _2
$a prognóza $7 D011379
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Mallela, Venkata Ramana $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic
700    1_
$a Ye, Wenjing $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic
700    1_
$a Sharif, Mahyar $u Department of Histology and Embryology, Faculty of Medicine in Pilsen, Charles University,Alej Svobody 1665/76, Pilsen 323 00, Czech Republic
700    1_
$a Ambrozkiewicz, Filip $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic
700    1_
$a Trailin, Andriy $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic
700    1_
$a Liška, Václav $u Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic; Department of Surgery, University Hospital in Pilsen and Faculty of Medicine in Pilsen, Charles University, Alej Svobody 80, Pilsen 323 00, Czech Republic
700    1_
$a Hemminki, Kari $u Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, Alej Svobody 1665/76, Pilsen 323 00, Czech Republic; Department of Cancer Epidemiology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany
773    0_
$w MED00005043 $t Critical reviews in oncology/hematology $x 1879-0461 $g Roč. 200 (20240523), s. 104391
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38795877 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110621 $b ABA008
999    __
$a ok $b bmc $g 2202039 $s 1231542
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 200 $c - $d 104391 $e 20240523 $i 1879-0461 $m Critical reviews in oncology/hematology $n Crit Rev Oncol Hematol $x MED00005043
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Archiving options